We are live on
!
Find out more
SGCM
Sand Grove Capital Management Portfolio holdings
AUM
$444M
1-Year Est. Return
131.11%
This Fund
S&P 500
This Quarter
Est. Return
+17.9%
1 Year Est. Return
+131.11%
3 Year Est. Return
+410.73%
5 Year Est. Return
+1,022.21%
10 Year Est. Return
+24,985.77%
AUM
$199M
AUM Growth
+$77.9M
(+65%)
Cap. Flow
+$65M
Cap. Flow
% of AUM
32.7%
Top 10 Holdings %
Top 10 Hldgs %
97.89%
Holding
14
New
8
Increased
1
Reduced
2
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$25.5M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
+$21.9M |
| 3 |
TXNM
TXNM Energy Inc
TXNM
|
+$18.5M |
| 4 |
BASE
Couchbase
BASE
|
+$14.5M |
| 5 |
COOP
Mr. Cooper
COOP
|
+$13.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FYBR
Frontier Communications
FYBR
|
+$28.4M |
| 2 |
SPR
Spirit AeroSystems
SPR
|
+$13.6M |
| 3 |
HES
Hess
HES
|
+$12.7M |
| 4 |
AZEK
The AZEK Co
AZEK
|
+$5.71M |
| 5 |
K
Kellanova
K
|
+$5.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.55% |
| 2 | Technology | 9.79% |
| 3 | Utilities | 9.62% |
| 4 | Energy | 8.98% |
| 5 | Financials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
1
DELISTED
Amedisys
AMED
| $30.3M | 15.27% |
308,254
+112,577
| +58% | +$10.7M |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $27.1M | 13.62% |
+211,124
| New | +$21.9M |
|
|
SWTX
3
DELISTED
SpringWorks Therapeutics
SWTX
| $26.9M | 13.54% |
+572,392
| New | +$25.5M |
|
|
BASE
4
DELISTED
Couchbase
BASE
| $19.4M | 9.79% |
+797,736
| New | +$14.5M |
|
|
TXNM
5
TXNM Energy Inc
TXNM
$6.44B
| $19.1M | 9.62% |
+339,204
| New | +$18.5M |
|
|
HES
6
DELISTED
Hess
HES
| $17.8M | 8.98% |
128,726
-94,185
| -42% | -$12.7M |
|
|
COOP
7
DELISTED
Mr. Cooper
COOP
| $15.7M | 7.89% |
+105,072
| New | +$13.5M |
|
|
K
8
DELISTED
Kellanova
K
| $13.7M | 6.88% |
171,815
-61,943
| -26% | -$5.06M |
|
|
FL
9
DELISTED
Foot Locker
FL
| $12.5M | 6.27% |
+508,528
| New | +$9.24M |
|
10
Omnicom Group
OMC
$23.5B
| $11.9M | 6.01% |
+166,039
| New | +$12.3M |
|
|
CCRN
11
DELISTED
Cross Country Healthcare
CCRN
| $4.2M | 2.11% |
+321,845
| New | +$4.42M |
|
|
AZEK
12
DELISTED
The AZEK Co
AZEK
| – | – |
-116,693
| Closed | -$5.71M |
|
|
FYBR
13
DELISTED
Frontier Communications
FYBR
| – | – |
-792,099
| Closed | -$28.4M |
|
|
SPR
14
DELISTED
Spirit AeroSystems
SPR
| – | – |
-393,815
| Closed | -$13.6M |
|
Similar funds
WCP
ACA
AFA
FWSM
JDLA
TAS
MLIC
TC
Sand Grove Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Sand Grove Capital Management held 14 positions worth $199M, up 65% from $121M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Sand Grove Capital Management deployed $65M of net new capital in Q2 2025, opening 8 new positions and adding to 1 existing holding. Its largest new stake was SpringWorks Therapeutics: 572,392 shares worth $26.9M.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 15% a quarter earlier, followed by Technology and Utilities.
On the sell side, the largest reduction was Hess, an estimated $12.7M trimmed.
- Sand Grove Capital Management's largest Q2 2025 buy was SpringWorks Therapeutics: 572,392 shares worth $26.9M.
- Sand Grove Capital Management added most to Amedisys in Q2 2025, an estimated $10.7M increase.
- Sand Grove Capital Management's biggest Q2 2025 reduction was Hess, cutting an estimated $12.7M.
- Sand Grove Capital Management fully exited Frontier Communications in Q2 2025, selling an estimated $28.4M.
- Sand Grove Capital Management's ten largest holdings make up 98% of its $199M portfolio in Q2 2025.
- Sand Grove Capital Management opened 8 new positions and closed 3 in Q2 2025.
- Sand Grove Capital Management's portfolio value rose 65% quarter-over-quarter to $199M.
Based on Sand Grove Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.